Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Cognitive Dysfunction × Abiraterone Acetate × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 3 Prostatic Neoplasms, Castration-Resistant 1 Prostate Cancer Metastatic 1 Metastatic Castration-resistant Prostate Cancer 1 Dementia 1 Cognitive Dysfunction 1 Cancer Pain 1

Interventions

enzalutamide 1 acetaminophen, aspirin, caffeine drug combination 1 Riluzole 1 Prednisone 1 Gonadotropin-Releasing Hormone 1 Abiraterone Acetate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03016741 2026-02-24

Cognitive Effects of Androgen Receptor Directed Therapies for Advanced Prostate Cancer

Northwestern University

Phase 4 Active not recruiting

Dementia, Prostatic Neoplasms, Cognitive Dysfunction, Prostatic Neoplasms, Castration-Resistant

Data powered by HemOnc (CC BY 4.0) Colophon ⚡